- RVL Pharmaceuticals plc press release ( NASDAQ: RVLP ): Q3 GAAP EPS of -$0.16 in-line.
- Revenue of $10.02M (+357.5% Y/Y) in-line.
For further details see:
RVL Pharmaceuticals plc GAAP EPS of -$0.16 in-line, revenue of $10.02M in-lineFor further details see:
RVL Pharmaceuticals plc GAAP EPS of -$0.16 in-line, revenue of $10.02M in-lineMarket Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.